Reitman reviews lab results and recommends a dosing schedule based on the severity of the deficiency
Athiras co-founder and chief executive, Leen Kawas, was placed on leave in 2021 after questions about manipulated images in her doctoral work, and a Washington State University investigation found her, with Harding, responsible for the fabrications
Consider which protocol you can realistically maintain long-term, as consistency determines outcomes with either compound
A preclinical safety evaluation published in ScienceDirect confirmed that BPC-157 showed no test-related toxicity in single-dose and repeated-dose studies across mice, rats, rabbits, and dogs, with no genetic or embryo-fetal toxicity detected
GFOGER (glycine-phenylalanine-hydroxyproline-glycine-glutamate-arginine) is a collagen-mimetic peptide
doi: 10.1016/j.ibneur.2022.05.005